Mipomersen Subcutaneous and Novoeight recombinant
Determining the interaction of Mipomersen Subcutaneous and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mipomersen
Brand name: Kynamro
Synonyms: Mipomersen
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mipomersen Subcutaneous-Novolin 70/30
- Mipomersen Subcutaneous-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Mipomersen Subcutaneous-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Mipomersen Subcutaneous-Novolin N
- Mipomersen Subcutaneous-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Mipomersen Subcutaneous-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Mirabegron
- Novoeight recombinant-Miradyne-3
- Novoeight recombinant-MiraLAX
- Novoeight recombinant-Miranel AF (Miconazole (Vaginal))
- Novoeight recombinant-Miranel AF (Miconazole Liquid)
- Novoeight recombinant-Mirapex